🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the safety, tolerability and efficacy of AT-1501 i...
Status
Withdrawn
Location
University of Alberta
Start Date
2021-02-19
Trial ID
NCT04711226
Treatments Being Tested
This study will evaluate the safety, tolerability and efficacy of AT-1501 i...
Status
Withdrawn
Location
University of Chicago
Start Date
2022-09-30
Trial ID
NCT05480657
Treatments Being Tested
This study will evaluate the safety and efficacy of AT-1501 compared with t...
Status
Completed
Location
University of California Los Angeles
Start Date
2023-08-30
Trial ID
NCT05983770
Treatments Being Tested
This is a phase 2a, multicenter, open-label study designed to evaluate the ...
Status
Terminated
Location
Liverpool Hospital
Start Date
2022-03-21
Trial ID
NCT05125068
Treatments Being Tested
This study will evaluate the long term safety and efficacy of AT-1501 (tego...
Status
Enrolling By Invitation
Location
University of California Los Angeles
Start Date
2023-10-25
Trial ID
NCT06126380
Treatments Being Tested
This study will evaluate the safety, PK, and efficacy of AT 1501 in patient...
Status
Recruiting
Location
University of Cincinnati
Start Date
2022-02-18
Trial ID
NCT05027906
Treatments Being Tested
This is a Phase 2a, multi-center, open label, multiple dose study of AT-150...
Status
Completed
Location
Barrows Neurological Institute
Start Date
2020-10-16
Trial ID
NCT04322149
Treatments Being Tested
Tegoprubart (AT-1501) is a monoclonal antibody. Antibodies are Y-shaped pro...
Status
Active Not Recruiting
Location
University of Chicago
Start Date
2024-03-04
Trial ID
NCT06305286
Treatments Being Tested